188 related articles for article (PubMed ID: 21278922)
1. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.
Deng Y; Deng H; Bi F; Liu J; Bemis LT; Norris D; Wang XJ; Zhang Q
Int J Biol Sci; 2011 Jan; 7(1):133-7. PubMed ID: 21278922
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA485-3p negatively regulates the transcriptional co-repressor
Du K; Zhang X; Lou Z; Guo P; Zhang F; Wang B; Chen L; Zhang C
Int J Biol Sci; 2018; 14(11):1445-1456. PubMed ID: 30262996
[TBL] [Abstract][Full Text] [Related]
3. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
4. CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
Porretti J; Dalton GN; Massillo C; Scalise GD; Farré PL; Elble R; Gerez EN; Accialini P; Cabanillas AM; Gardner K; De Luca P; De Siervi A
Int J Cancer; 2018 Aug; 143(4):897-906. PubMed ID: 29536528
[TBL] [Abstract][Full Text] [Related]
5. C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells.
Deng Y; Li H; Yin X; Liu H; Liu J; Guo D; Shi Z
Med Sci Monit; 2018 Oct; 24():7614-7624. PubMed ID: 30356033
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-212 Regulates the Expression of Olfactomedin 1 and C-Terminal Binding Protein 1 in Human Endometrial Epithelial Cells to Enhance Spheroid Attachment In Vitro.
Kottawatta KS; So KH; Kodithuwakku SP; Ng EH; Yeung WS; Lee KF
Biol Reprod; 2015 Nov; 93(5):109. PubMed ID: 26377223
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer.
Deng Y; Deng H; Liu J; Han G; Malkoski S; Liu B; Zhao R; Wang XJ; Zhang Q
Mol Carcinog; 2012 Jun; 51(6):500-7. PubMed ID: 21681822
[TBL] [Abstract][Full Text] [Related]
9. The CtBP1-p300-FOXO3a transcriptional complex represses the expression of the apoptotic regulators Bax and Bim in human osteosarcoma cells.
Li C; Xiao XQ; Qian YH; Zhou ZY
J Cell Physiol; 2019 Dec; 234(12):22365-22377. PubMed ID: 31074088
[TBL] [Abstract][Full Text] [Related]
10. Loss of full length CtBP1 expression enhances the invasive potential of human melanoma.
Winklmeier A; Poser I; Hoek KS; Bosserhoff AK
BMC Cancer; 2009 Feb; 9():52. PubMed ID: 19216735
[TBL] [Abstract][Full Text] [Related]
11. CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.
Deng H; Liu J; Deng Y; Han G; Shellman YG; Robinson SE; Tentler JJ; Robinson WA; Norris DA; Wang XJ; Zhang Q
J Invest Dermatol; 2013 May; 133(5):1294-301. PubMed ID: 23303449
[TBL] [Abstract][Full Text] [Related]
12. CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.
Dalton GN; Massillo C; Scalise GD; Duca R; Porretti J; Farré PL; Gardner K; Paez A; Gueron G; De Luca P; De Siervi A
Cell Death Dis; 2019 Apr; 10(4):299. PubMed ID: 30931931
[TBL] [Abstract][Full Text] [Related]
13. CtBP1 overexpression in keratinocytes perturbs skin homeostasis.
Deng H; Li F; Li H; Deng Y; Liu J; Wang D; Han G; Wang XJ; Zhang Q
J Invest Dermatol; 2014 May; 134(5):1323-1331. PubMed ID: 24280726
[TBL] [Abstract][Full Text] [Related]
14. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
[TBL] [Abstract][Full Text] [Related]
16. miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1.
Han Y; Bi Y; Bi H; Diao C; Zhang G; Cheng K; Yang Z
Hum Cell; 2016 Jan; 29(1):30-6. PubMed ID: 26337822
[TBL] [Abstract][Full Text] [Related]
17. Role of miR-214 in regulation of β-catenin and the malignant phenotype of melanoma.
Prabhakar K; Rodrίguez CI; Jayanthy AS; Mikheil DM; Bhasker AI; Perera RJ; Setaluri V
Mol Carcinog; 2019 Nov; 58(11):1974-1984. PubMed ID: 31338875
[TBL] [Abstract][Full Text] [Related]
18. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
[TBL] [Abstract][Full Text] [Related]
19. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma.
Zhang XL; Huang CX; Zhang J; Inoue A; Zeng SE; Xiao SJ
Oncol Rep; 2013 Aug; 30(2):809-14. PubMed ID: 23756565
[TBL] [Abstract][Full Text] [Related]
20. Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells.
Noguchi S; Mori T; Otsuka Y; Yamada N; Yasui Y; Iwasaki J; Kumazaki M; Maruo K; Akao Y
J Biol Chem; 2012 Apr; 287(15):11769-77. PubMed ID: 22354972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
